Kiromic BioPharma Announces Deltacel™ Phase 1 Clinical Trial Enters Patient Recruitment Phase at Beverly Hills Cancer Center

HOUSTON--(BUSINESS WIRE)--Nov 9, 2023--

Related Keywords

Beverly Hills ,Texas ,United States ,Houston ,California ,Kiromic Biopharma ,Linda Phelan Dyson ,Tirtht Patel ,Pietro Bersani ,Linkedin ,Securities Exchange ,Twitter ,Corporate Communications ,Kiromic Biopharma Inc ,Beverly Hills Cancer Center ,Gamma Deltat Cell ,Patients With Stage ,Chief Executive Officer ,Hills Cancer Center ,Gamma Deltat Cells ,Securities Exchange Act ,Annual Report ,Phelan Dyson ,Business Wire ,Region ,